TotalMarketCap

Immucell

ICCCNasdaq United StatesHealth CareBiotechnology: In Vitro & In Vivo Diagnostic Substances

Market cap

$89.687 M

$9.88 -4.77%

Close of 6 Nov 2026

As of 6 Nov 2026, Immucell (ICCC) has a market capitalization of $89.7M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$26.5M

#2894 by revenue

Earnings

-$1.04M

Loss-making

Shares outstanding

9,082,197

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: In Vitro & In Vivo Diagnostic Substances, ranked by market cap

All 19 →
  1. #10Anbio BiotechnologyNNNN$529.5M
  2. #11Alpha TeknovaTKNO$484.9M
  3. #12ImmucellICCC$89.7M
  4. #13Insight Molecular DiagnosticsIMDX$79.2M
  5. #14BiomericaBMRA$7.40M

What if Immucell were worth as much as…

Open the what-if tool →

Gold $28.2T

$3,109,036

Per share 314,839× higher

Bitcoin $1.53T

$168,224.50

Per share 17,035× higher

Apple $5.02T

$552,265.34

Per share 55,926× higher

Or at a round number

$200.0M$500.0M$1.00B$2.00B

Where these numbers come from

Share counts and financials for Immucell are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.